Renal arteriolar C4d deposition: A novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy

Transplantation

Volumn 96, Issue 2, 2013, Pages 217-223

  Laskin, Benjamin L ^a   Maisel, Julia ^a   Goebel, Jens ^a   Yin, Hong J ^b   Luo, Guangju ^b   Khoury, Jane C ^b   Davies, Stella M ^b   Jodele, Sonata ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Complement; Hematopoietic cell transplantation; Pediatrics; Thrombotic microangiopathy

Indexed keywords

COMPLEMENT COMPONENT C4D;

ARTERIOLE; ARTICLE; AUTOPSY; CAPILLARY; CHILD; CLINICAL ARTICLE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FEMALE; GLOMERULUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATED THROMBOTIC MICROANGIOPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TUBULE BASEMENT MEMBRANE; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ARTERIOLES; BIOLOGICAL MARKERS; CAPILLARIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMPLEMENT C4B; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KIDNEY; MALE; PEPTIDE FRAGMENTS; THROMBOTIC MICROANGIOPATHIES;

EID: 84880571342     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829807aa     Document Type: Article

References (53)

1. Batts ED, Lazarus HM. Diagnosis and treatment of transplantationassociated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 2007; 40: 709.
2. Laskin BL, Goebel J, Davies SM, et al. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantationassociated thrombotic microangiopathy. Blood 2011; 118: 1452.
3. Nakamae H, Yamane T, Hasegawa T, et al. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol 2006; 81: 525.
4. Changsirikulchai S, Myerson D, Guthrie KA, et al. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009; 4: 345.
5. Stavrou E, Lazarus HM. Thromboticmicroangiopathy in haematopoietic cell transplantation: an update. Mediterr J Hematol Infect Dis 2010; 2: e2010033.
6. Siami K, Kojouri K, Swisher KK, et al. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008; 85: 22.
7. Chan GS, Lam MF, Au WY, et al. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation. Nephrology (Carlton) 2008; 13: 322.
8. Glezerman IG, Jhaveri KD, Watson TH, et al. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T celldepleted hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16: 976.
9. Laskin BL, Goebel J, Davies SM, et al. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. Bone Marrow Transplant 2011; 46: 682.
10. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 2006; 17: 1995.
11. Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int 2006; 69: 430.
12. Cohen EP, Drobyski WR,Moulder JE. Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 571.
13. Ellis MJ, Parikh CR, Inrig JK, et al. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 2008; 8: 2378.
14. Kersting S, Koomans HA, Hene RJ, et al. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 2007; 39: 359.
15. Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010; 10: 1517.
16. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 1676.
17. Mengel M, Sis B, Haas M, et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563.
18. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.
19. Mii A, Shimizu A, Kaneko T, et al. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Pathol Int 2011; 61: 518.
20. Mii A, Shimizu A, Masuda Y, et al. Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation. Pathol Int 2011; 61: 34.
21. Batal I, Girnita A, Zeevi A, et al. Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol 2008; 21: 1490.
22. Kikic Z, Regele H, Nordmeyer V, et al. Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies. Transplantation 2011; 91: 440.
23. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046.
24. Troxell ML, Pilapil M, Miklos DB, et al. Renal pathology in hematopoietic cell transplantation recipients. Mod Pathol 2008; 21: 396.
25. Troxell ML, Weintraub LA, Higgins JP, et al. Comparison of C4d immunostaining methods in renal allograft biopsies. Clin J Am Soc Nephrol 2006; 1: 583.
26. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779.
27. Bohmig GA, Exner M, Habicht A, et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091.
28. Haas M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006; 6: 1829.
29. Fedrigo M, Gambino A, Tona F, et al. Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplantation 2010; 90: 791.
30. Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allograftsupdated Banff grading schema. Am J Transplant 2011; 11: 1792.
31. Kozlowski T, Andreoni K, Schmitz J, et al. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts. Liver Transpl 2012; 18: 641.
32. Yousem SA, Zeevi A. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies. Am J Surg Pathol 2012; 36: 987.
33. Landin L, Cavadas PC, Ibanez J, et al. CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 2009; 87: 776.
34. Kanitakis J, McGregor B, Badet L, et al. Absence of C4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study. Transplantation 2007; 84: 265.
35. Chan GS, Tse KC, Lam MF, et al. Thrombotic microangiopathy in an allograft kidney: a diagnostic challenge. Histopathology 2006; 48: 775.
36. Troxell ML, Norman D, Mittalhenkle A. Glomerular fibrin thrombi in ABO and crossmatch compatible renal allograft biopsies. Pathol Res Pract 2011; 207: 15.
37. Meehan SM, Kremer J, Ali FN, et al. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies. Clin J Am Soc Nephrol 2011; 6: 395.
38. Cohen D, Colvin RB, Daha MR, et al. Pros and cons for C4d as a biomarker. Kidney Int 2012; 81: 628.
39. Cohen D, Koopmans M, Kremer Hovinga IC, et al. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum 2008; 58: 2460.
40. Shen Y, Chen XW, Sun CY, et al. Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases. Lupus 2010; 19: 1195.
41. Lee J, Romero R, Xu Y, et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, antihuman leukocyte antigen antibodies, and C4d. PLoS One 2011; 6: e16806.
42. Cohen D, Buurma A, Goemaere NN, et al. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. J Pathol 2011; 225: 502.
43. Mannon RB, Matas AJ, Grande J, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant 2010; 10: 2066.
44. Mengel M, Bogers J, Bosmans JL, et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5: 1050.
45. Papadimitriou JC, Drachenberg CB, Ramos E, et al. Antibodymediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies. Transplantation 2013; 95: 128.
46. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
47. Perkowska-Ptasinska A, Sulikowska-Rowinska A, Pazik J, et al. Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report. Transplant Proc 2006; 38: 295.
48. Hewamana S, Austen B, Murray J, et al. Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy. Eur J Haematol 2009; 83: 277.
49. Fang CJ, Richards A, Liszewski MK, et al. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 2008; 143: 336.
50. Worel N, Greinix HT, Leitner G, et al. ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy. Transfus Apher Sci 2007; 36: 297.
51. Ho VT, Cutler C, Carter S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 571.
52. Choi CM, Schmaier AH, Snell MR, et al. Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment. Drugs 2009; 69: 183.
53. de Latour RP, Xhaard A, Fremeaux-Bacchi V, et al. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy. Br J Haematol 2013; 161: 279.